OVERVIEW
YNIOS PHARMA is a biotech founded in March 2022 by Philippe Van Wesepoel and Jean François Plucker, the same founders of biotech OLYS Pharma which focusses on topical neuro-cutaneous treatments. *
* Diabetic Peripheral Neuropathic Pain – Neuralgia of the trigeminocervical complex (Migraine) – Low back pain – Sciatica pain – Rheumatoid arthritis pain.
YNIOS PHARMA set out to build a platform for the oral or parenteral administration of the treatment of diseases due to cellular degeneration induced by inflammation, such as Acute Ischemic Stroke (AIC), Chronic Inflammatory Bowel Disease (IBD) and Charcot-Marie-Tooth disease (CMT1A). The company is currently validating its proof of concept in order to start preclinical programs.
THE FOUNDERS


MANAGEMENT
The founders are the Associate Directors of the company. They combine extensive experience in management, international business development, intellectual property, research and innovation, and partnership strategies.